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Abstract A reference material for the biological monitor-
ing of occupational exposure to toluene, benzene and
phenol was prepared. O-cresol and hippuric acid (metabo-
lites of toluene) are used for the biological monitoring of
occupational exposure to toluene. Phenol, a metabolite of
benzene, is used for the biological monitoring of exposure
to benzene, but phenol can of course also be used as an
indicator of exposure to phenol as well. The reference
material (RM) used for the determination of these metab-
olites was prepared by freeze-drying pooled urine samples
obtained from healthy persons occupationally exposed to
toluene and those taking part in an inhalation experiment.
Tests for homogeneity and stability were performed by
determining urine concentrations of o-cresol, hippuric acid,
creatinine and phenol. To investigate the stability of the
RM, the urinary concentrations of o-cresol and phenol were
monitored for eighteen months using GC and HPLC, while
those of hippuric acid and creatinine were followed for five
and six years, respectively, using HPLC. Analysis of
variance showed that the concentrations did not change.
The certified concentration values (and their uncertainties)
of the substances in this reference material (phenol
concentration c=6.46±0.58 mg l−1; o-cresol concentration
c=1.17±0.15 mg l−1; hippuric acid concentration c=1328±
30 mg l−1; creatinine concentration c=0.82±0.10 g l−1)
were evaluated via the interactive statistical programme
IPECA.
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Introduction
In Europe there are thousands of industrial workers that are
exposed to toluene. Toluene has narcotic and genotoxic
effects [1, 2]. A number of workplaces have been classified
as being hazardous with respect to toluene [3].
Toluene is one of the most important industrial organic
chemicals. It is absorbed by humans through the lungs, and
84% of the toluene absorbed is metabolized. Cytochrome
P-450 enzymes are involved in several steps of the
transformation of toluene. Toluene is metabolized into
benzoic acid, which is further conjugated with glycine to
form hippuric acid. Small amounts of absorbed toluene
(1%) are metabolized at the aromatic ring and excreted into
the urine as o-, m-, and p-cresol [4–10].
Determinations of the concentrations of o-cresol and
hippuric acid is used for biological monitoring of exposure
to toluene. O-cresol is a more specific indicator of toluene
exposure, because hippuric acid and p-cresol are natural
components of urine [4–10].
In recent studies, another metabolite useful for the
biological monitoring of toluene, S-p-toluylmercapturic
acid, which is not a natural component of urine, has been
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described [11, 12]. However, in practice no BAT (biological
tolerance values) have been established for this substance
yet [13].
Workers exposed to toluene have to undergo regular
medical check-ups, which consist of a basic examination
and the determination of urinary creatinine once each year.
The concentrations of hippuric acid and o-cresol in urine
are determined 1–3 times per year [14], so there is an urgent
need for a certified reference material (RM) for those
metabolites.
Biological limit values from biological exposure tests of
urine and the conditions that should be used when sampling
biological material during biological exposure tests are
summarized in Decree No. 432/2003 Coll. [15].
In toxicology, the amount of toluene metabolite
excreted in urine is expressed in either mg/l of urine or
in the concentrations per mg of excreted creatinine.
Creatinine is excreted from the human body at a
relatively stable rate which is only slightly influenced
by physical exercise and stress and is not influenced by
diet, temperature or volume of liquid imbibed. There are
limitations to the monitoring of urinary creatinine
excretion in the place of 24-h urine collection (the CVs
reported by investigators have varied from 5.6 to 22%)
[16]. However, in occupational health praxes, the use of
corrected urinary creatinine excretion is preferred to 24-h
urine sampling. Thus, accurate creatinine determination
becomes at least as important as the accurate determination
of the analyte itself during the quality assurance of
exposure analysis and exposure assessment.
The other analyte included in the RM developed here is
phenol, which is a metabolite of benzene but can of course
also be used as an indicator of exposure to phenol.
Experimental
The reference material was prepared by freeze-drying
pooled urine samples [17] obtained from healthy persons
occupationally exposed to toluene and those taking part in
an inhalation experiment (9 males and 15 females, average
age 47.2±14.9). Aliqots of urine (12 ml) were dispensed
into 20-ml glass vials using an automatic Nichiryo (Tokyo,
Japan) Macromaster pipette, freeze-dried, and the vials
were hermetically stoppered. Appropriate guidelines, such
as Czech Metrological Institute Methodology 017 MP-
C001-02 [18], ISO Guide 35 2002 [19] and ISO Guide 34
2003 [20] were followed during RM preparation.
Reconstitution of freeze-dried material
The freeze-dried material was reconstituted for analysis by
adding 12.00 ml of bidistilled water and then by agitating
this with a laboratory roller mixer at a frequency of 1 s−1
for 10 min.
Instruments
HPLC was performed with an Agilent (Palo Alto, CA,
USA) 1100 Series liquid chromatograph equipped with an
autosampler and diode array detector as well as ChemSta-
tion software for analyte concentration evaluation.
GC was performed using:
– An Agilent 6890N gas chromatograph equipped with
an autosampler and FID as well as ChemStation
software for analyte concentration evaluation;
– An HP5890A gas chromatograph with FID and ECD;
– A Finnigan GCQ gas chromatograph with MS detector
(ion trap).
Table 1 Testing the concentration of o-cresol in RM 6010 for homogeneity
Metabolite sample O-cresol (mg l−1 urine)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Mean
value
1.12 1.13 1.12 1.12 1.12 1.13 1.15 1.12 1.13 1.14 1.14 1.14 1.15 1.13 1.12
SD 0.019 0.005 0.039 0.010 0.016 0.019 0.028 0.021 0.006 0.014 0.010 0.024 0.013 0.007 0.025
Table 2 Testing the concentration of phenol in RM 6010 for homogeneity
Metabolite samples Phenol (mg l−1 urine)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Mean value 6.22 6.10 6.15 6.19 6.20 6.23 6.32 6.16 6.27 6.24 6.23 6.53 6.38 6.25 6.29
SD 0.04 0.04 0.05 0.04 0.10 0.15 0.31 0.11 0.04 0.12 0.04 0.31 0.13 0.08 0.12
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Methods
Creatinine concentrations were determined using an HPLC
method [21] and spectrophotometrically (Jaffe’s method)
[22].
Two approaches to the HPLC determination of hippuric
acid were used: separation on C-18 columns and a
Chromolith Performance RP/18e 100/4.6 with a Chromolith
Guard Cartridge RP/18e 10/4.6 (Merck KgaA, Darmstadt,
Germany) [23].
It was not necessary to purify the urine samples for both
creatinine and hippuric determination; these were diluted
with the mobile phase for the HPLC chromatography of
hippuric acid and with bidistilled water for creatinine
determination.
The phenol and o-cresol excreted in urine as glucur-
onides and sulfates were released via acidic hydrolysis
performed by either simultaneous steam distillation or
diisopropylether extraction, and so they were separated
from most of the urine matrix. For phenol and o-cresol, four
combinations of purification, separation and detection steps
were employed [24]:
1. Gas chromatography with flame ionisation detection
(GC/FID) (acidic hydrolysis followed by diisopropy-
lether extraction);
2. Gas chromatography with flame ionisation detection
(GC/FID) (acidic hydrolysis with simultaneous steam
distillation followed by diisopropylether extraction);
3. Gas chromatography with electron capture detection
(GC/ECD) (acidic hydrolysis with simultaneous steam
distillation, derivatisation and heptane extraction);
4. Liquid chromatography with UV detection (HPLC)
(acidic hydrolysis with simultaneous steam distillation
—the same procedure as in procedures 2 and 3 above).
Calibration and traceability
Standard Reference Material NIST 914a creatinine was
used as the calibration material for determinations of
creatinine. Pure chemicals [phenol, no. 77610, lot 421187/1,
61703052, 99.5% (w/w)(GC), o-cresol no. 60990, lot 14781/1,
14302004, 99.5% (w/w)(GC) (Fluka, Buchs, Switzerland)
and pure chemical hippuric acid (N-benzoylaminoacetic
acid), >99% (Sigma-Aldrich, St. Louis, MO, USA), no.
H-6375, lot 30K34723) were used for calibration when
determining phenol and o-cresol concentrations. The
declared purity was taken into account in the calibration
function. This allowed the traceability of the results
obtained to the pure substances mentioned above to be
established.
Methods were validated by the method of standard
addition, and results were evaluated using EffiValidation 3
software (EffiChem, Lysice, Czech Republic).
Homogeneity tests
Homogeneity testing was carried out by determining the
phenol and o-cresol concentrations in fifteen units of RM
(every 75th sample from the whole batch—not randomly
chosen so as to avoid trend inhomogeneity). Three replicate
analyses from each unit were performed using method GC-
FID-1 in the authors’ laboratory.
Homogeneity testing for hippuric acid and creatinine
concentration determinations was performed in ten units of
RM (each 100th sample from the whole batch). Six
replicate analyses from each unit were performed in the
authors’ laboratory using HPLC methods.
Stability tests
In order to make sure that the analyses were performed
under conditions of good repeatability, the samples were
Table 4 Testing the concentration of creatinine in RM 6010 for homogeneity
Metabolite sample Creatinine (g l−1 urine)
1 2 3 4 5 6 7 8 9 10
Mean value 0.75 0.72 0.72 0.72 0.71 0.69 0.72 0.70 0.71 0.73
SD 0.03 0.05 0.03 0.05 0.03 0.04 0.05 0.06 0.07 0.02
Table 3 Testing the concentration of hippuric acid in RM 6010 for homogeneity
Metabolite sample Hippuric acid (mg l−1 urine)
1 2 3 4 5 6 7 8 9 10
Mean value 1350.5 1350.5 1334.1 1348.3 1324.4 1334.4 1323.5 1322.8 1331.7 1325.0
SD 14.7 12.8 14.0 41.5 20.3 14.6 18.4 15.4 10.2 12.2
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analysed isochronically, i.e., all of the samples were analysed
on the same day. To test the stabilities of phenol and o-cresol,
two units of candidate RM were combined into one. The
urinary concentrations were determined in six test portions
of this RM after 0, 3, 6, 9, 18 months after freeze-drying
and storing the freeze dried material at −18 °C. Again, the
method GC-FID-1 was used in the authors’ laboratory. The
stability of the creatinine concentration in RM 6008 was
followed for six years, and the stability of the hippuric acid
concentration in RM 6009 for five years.
Design of interlaboratory comparison
For the certification run, laboratories accredited by the
Czech Accreditation Institute for this type of analysis or
laboratories holding a Certificate for Toxicological Analy-
ses in Biological Materials from the German External
Quality Assessment Scheme Intercomparison Programme
took part. Methods 1–4 were employed for phenol and
o-cresol. Six individual units were pooled and then six
subsamples taken from this pool were analysed over three
consecutive days using each method. The laboratories were
asked to carry out six replicate analyses of the RM each
day. The aim of this repeated testing over a three-day period
was to check the stabilities of the analytical methods
employed. Hippuric acid and creatinine concentration
determinations were carried out on one sample over three
consecutive days. The analytical methods mentioned above
were employed.
Results and discussion
Homogeneity tests
The results of homogeneity testing were examined using
one-way analysis of variance (ANOVA). No significant
between-unit differences were found for the concentra-
tions of all of the analytes mentioned above considering
the analytical uncertainty and the significance level used
( α=0.05; Tables 1, 2, 3 and 4). The overall mean±standard
deviation values calculated for phenol, o-cresol, hippuric
ac id and crea t in ine were 6 .25±0 .09 mg l−1 ,
1 .13±0 .01 mg l− 1 , 1334 .5±17 .4 mg l− 1 and
0.72±0.04 g l−1, respectively.
Stability tests
The results from testing the stabilities of the o-cresol,
hippuric acid, phenol and creatinine concentrations in RM
preliminary batch of RM 6010
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Fig. 1 Results from testing the stabilities of the o-cresol concen-
trations in samples stored in darkness at 3–6 °C, (error bars are
standard deviations of three replicate analyses)
in RM 6009
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Fig. 3 Results from testing the stabilities of the hippuric acid
concentrations in samples stored in darkness at 3–6 °C (error bars
are standard deviations of six replicate analyses)
in preliminary batch of RM
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Fig. 2 Results from testing the stabilities of the phenol concentrations
in samples stored in darkness at 3–6 °C (error bars are standard
deviations of three replicate analyses)
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Fig. 4 Results from testing the stabilities of the creatinine concen-
trations in samples stored in darkness at 3–6 °C (error bars are
standard deviations of six replicate analyses)
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are summarized in (Figs. 1, 2, 3 and 4). Using one-way
ANOVA, no concentration changes were found for any of
these analytes over the period followed considering the
analytical uncertainties and the significance level used
(α=0.05). The overall mean±standard deviation calculated
for phenol, o-cresol, hippuric acid and creatinine were
9.41±0.24 mg l−1, 1.05±0.03 mg l−1, 327.9±14 mg l−1 and
1.26±0.073 mg l−1, respectively.
Evaluation of interlaboratory comparison
The results from the interlaboratory comparison are
summarized in Figs. 5, 6, 7 and 8.
The laboratory results obtained on three consecutive
days were evaluated for agreement using one-way ANOVA.
All of the laboratory tests passed this test. Then the
individual laboratory means were evaluated using the
IPECA interactive statistical programme [25]. The evalua-
tion involves testing the variance of the laboratory data
using the Cochran, Bartlett and standard error tests, and
testing outlying laboratory means using the combined
Grubb’s, Dean–Dixon, Huber, coefficient of skewness and
kurtosis tests. The results from laboratory 6 for cresol were
identified as being outliers for statistical reasons and were
rejected from further data processing, because the labora-
tory was suspected of producing biased results for technical
(calibration) reasons. Two outliers in the variance were
found in the data sets obtained for phenol (laboratory 2 and 3).
These data sets were therefore rejected from the calcu-
lation. To derive the certified values of the individual
analytes, the overall arithmetic mean was calculated from
the remaining laboratory means, and the combined uncer-
tainty was calculated as U ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
u2i þ u2h þ u2s
q
where u2i is
the uncertainty in the interlaboratory analyses (standard
deviation of the overall mean), u2h is the uncertainty in the
homogeneity testing (standard deviation of the overall
mean), and u2s is the uncertainty in the stability testing
(standard deviation of the overall mean).
The following certified values were obtained using the
above approach:
– phenol: (6.46±0.58) mg l−1
– o-cresol: (1.17±0.15) mg l−1
– hippuric acid: (1328±30) mg l−1
– creatinine: (0.82±0.10) g l−1
The uncertainties given are combined uncertainties
(coverage factor=1).
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Fig. 5 Results from interlaboratory comparison for the determination
of o-cresol in urine (error bars are standard deviations of six replicate
analyses of each laboratory)
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Fig. 7 Results from interlaboratory comparison for the determination
of hippuric acid in urine (error bars are standard deviations of six
replicate analyses of each laboratory)
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Fig. 6 Results from interlaboratory comparison for the determination
of phenol in urine (error bars are standard deviations of six replicate
analyses of each laboratory)
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Fig. 8 Results from interlaboratory comparison for the determination
of creatinine in urine (error bars are standard deviations of six
replicate analyses of each laboratory)
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Conclusion
The reference material CZ 6010 for o-cresol and hippuric
acid in human urine resulting from occupational toluene
exposure has been prepared. Phenol and creatinine concen-
trations were also determined in the material. The certified
values are unweighted arithmetical averages of accepted
results from an interlaboratory comparison, and their
uncertainties are combined uncertainties (coefficient k=1)
evaluated from the standard uncertainties of the interlabora-
tory comparison, homogeneity and stability tests. The
creatinine concentration was certified so that the contents
of o-cresol, hippuric acid and phenol can be related to this
parameter, as is often done in occupational health studies.
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